Dietary Green Tea Confection For Resolving Gut Permeability-Induced Metabolic Endotoxemia In Obese Adults
Part of paid clinical trials in Columbus, Ohio.
- Sponsor
- Ohio State University
- Study ID
- NCT03413735
- Status
- Completed
Conditions
- Endotoxemia
- Inflammation
- Obesity
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 50 Years
- Healthy Volunteers
- Accepted
Interventions
- Green Tea Extract — OTHERConfections containing green tea extract that will be ingested daily for 4 weeks
- Placebo — OTHERConfections containing no green tea extract that will be ingested daily for 4 weeks
Study Details
This study is focused on assessing gastrointestinal-level improvements by which green tea limits metabolic endotoxemia. It is completed in two phases. Phase I consists of a pharmacokinetic study to examine the bioavailability of green tea catechins among lean and obese persons who consumed a single dose of a green tea extract (GTE)-containing confection. These persons will then complete phase 2, which consists of a parallel design randomized controlled in which lean and obese persons will consume placebo or GTE confections. It is expected that catechin-rich green tea will improve gut barrier function to prevent endotoxin translocation and associated low-grade inflammation. Outcomes will therefore support dietary recommendations for green tea to alleviate obesity-related inflammatory responses. Specifically, the study is expected to demonstrate that a green tea confection snack food can attenuate metabolic endotoxemia in association with restoring gastrointestinal health.
Key Dates
- Start date
- Aug 29, 2018
- Status verified
- May 2025
- Primary completion
- Jul 30, 2019
- Completion
- Jul 30, 2019
Study Design
- Enrollment
- 40 participants (actual)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- PREVENTION
Arms
- Placebo Comparator: Placebo ConfectionConfection without green tea extract consumed daily for 4 weeks
- Experimental: Green Tea Extract-ConfectionConfection with green tea extract consumed daily for 4 weeks
Primary Outcome Measure
Endotoxin [ Time Frame: Week 0 - Fasting ]
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Ohio State University | Columbus | Ohio | 43210 | - |
Find similar trials in Columbus, OH
Related Studies
- RESET System Pivotal Trial (Rev F)Recruiting · Morphic Medical Inc. · Washington D.C., District of Columbia
- Low Dose ColchicinE in pAtients With Peripheral Artery DiseasE to Address Residual Vascular RiskPHASE3 · Recruiting · Population Health Research Institute · New Haven, Connecticut
- Caloric Restriction and Activity to Reduce Chemoresistance in B-ALLPHASE2 · Recruiting · Etan Orgel · Los Angeles, California
- Inspiratory Muscle Training in Obese Breast Cancer SurvivorsRecruiting · Ohio State University Comprehensive Cancer Center · Columbus, Ohio